Chemotherapy upregulated HLA-G by inhibiting DNMT1 and inducing demethylation of TAP1, providing opportunities for anti-HLA-G CAR-NK cells to eliminate cancer cells [22]. This evidence concerns the gene HLA-G and cancer.